Marshall Wace’s Sabra Healthcare REIT SBRA Stock Holding History

Marshall Wace’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.64M	Buy	135,438 +27,522	+26%	+$546K	﹤0.01%	1695
2026 Q1	$2.08M	Buy	+107,916	New	+$2.13M	﹤0.01%	1762
2025 Q4	–	Sell	-16,070	Closed	-$300K	–	3422
2025 Q3	$300K	Buy	+16,070	New	+$300K	﹤0.01%	2432
2024 Q2	–	Sell	-140,253	Closed	-$2.07M	–	2904
2024 Q1	$2.07M	Buy	+140,253	New	+$1.94M	﹤0.01%	1351
2023 Q3	–	Sell	-156,014	Closed	-$1.84M	–	2620
2023 Q2	$1.84M	Buy	+156,014	New	+$1.78M	﹤0.01%	1442
2021 Q1	–	Sell	-20,644	Closed	-$359K	–	2814
2020 Q4	$359K	Buy	+20,644	New	+$329K	﹤0.01%	1604
2020 Q1	–	Sell	-197,186	Closed	-$4.21M	–	2007
2019 Q4	$4.21M	Buy	+197,186	New	+$4.42M	0.03%	583
2015 Q3	–	Sell	-71,583	Closed	-$1.84M	–	1037
2015 Q2	$1.84M	Buy	+71,583	New	+$2.03M	0.02%	493
2014 Q4	–	Sell	-215,059	Closed	-$5.23M	–	944
2014 Q3	$5.23M	Buy	+215,059	New	+$5.96M	0.08%	282

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Marshall Wace's SBRA Position: Q2 2026 in Review

Marshall Wace increased its Sabra Healthcare REIT (SBRA) stake by 26% in Q2 2026, buying an estimated $546K and bringing the position to 135,438 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

Marshall Wace first reported a position in SBRA in Q3 2014 and has held it in 9 quarters since. The position peaked at $5.23M in Q3 2014. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Marshall Wace held 135,438 shares of Sabra Healthcare REIT worth $2.64M as of Q2 2026.
Marshall Wace bought 27,522 Sabra Healthcare REIT shares in Q2 2026, an estimated $546K.
Sabra Healthcare REIT made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1695 holding.
Marshall Wace first reported a position in Sabra Healthcare REIT in Q3 2014 and has held it in 9 quarters since.
Marshall Wace's Sabra Healthcare REIT position peaked at $5.23M in Q3 2014.
466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.